US equities |
SPCX $168.23 ▲+5.83% NVDA $237.41 ▲+1.48% MU $1,065.99 ▼-0.83% TSLA $378.69 ▲+2.18% MSFT $525.67 ▲+1.57% SNDK $1,711.72 ▼-0.48% INTC $117.04 ▼-1.92% META $743.65 ▲+2.14%
FinancialContent

InspireMD Inc. - Common Stock (NQ:NSPR)

0.6000 -0.0200 (-3.23%)
Delayed Quote Updated: 1:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InspireMD Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
InspireMD NSPR Q1 2026 Earnings Transcript ↗
InspireMD NSPR Q1 2026 Earnings Transcript 
Via The Motley Fool
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
InspireMD (NSPR) Q4 2025 Earnings Transcript ↗
InspireMD (NSPR) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
InspireMD (NSPR) Q2 2025 Earnings Transcript ↗
InspireMD (NSPR) Q2 2025 Earnings Transcript 
Via The Motley Fool
InspireMD (NASDAQ:NSPR) Q1 Beat Fails to Impress as Stock Slides ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
InspireMD (NSPR) Q3 2025 Earnings Transcript ↗
InspireMD (NSPR) Q3 2025 Earnings Transcript 
Via The Motley Fool
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
InspireMD Inc (NSPR) Q3 2025 Earnings Top Estimates, Fueled by Strong Sales Beat ↗
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system. 
Via Chartmill
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
A Look Ahead: InspireMD's Earnings Forecast ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Preview: InspireMD's Earnings ↗
 
Via Benzinga
News headline image
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
From RxSight, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic ↗
The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets. 
Via Stocktwits
News headline image
Earnings Scheduled For May 9, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NSPR Stock Earnings: InspireMD Misses EPS, Misses Revenue for Q2 2024 ↗
NSPR stock results show that InspireMD missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 12, 2025 ↗
 
Via Benzinga
News headline image
NSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024 ↗
NSPR stock results show that InspireMD missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
NSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023 ↗
NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 6, 2024 ↗
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
< Previous 1 2 3 Next >